Počet záznamov: 1
Real-world safety and efficacy of nivolumab for ≥ 2nd line treatment of metastatic renal cell carcinoma: A retrospective cohort study in Croatia, Hungary, and Malta
SYS 0173183 LBL 00000naa^^22^^^^^^^^450 005 20210624125028.2 100 $a 20210609d2021 m y0sloy0103 ba 101 0-
$a eng $d eng 102 $a SK 200 1-
$a Real-world safety and efficacy of nivolumab for ≥ 2nd line treatment of metastatic renal cell carcinoma: A retrospective cohort study in Croatia, Hungary, and Malta $f Eduard Vrdoljak ... [et al.] 215 $c ilustr., grafy, tab. 320 $a Bibliogr. odkazy 320 $a Res. angl. 463 -1
$1 001 sllk_un_cat*0172570 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 68, no. 1 (2021), s. 208-215 $1 210 $a Bratislava $c AEPress $d 2021 $1 215 $a s. 1-226 606 1-
$3 sllk_un_auth*d002292 $a karcinóm renálnych buniek $x farmakoterapia $2 mesh 606 2-
$3 sllk_un_auth*d009362 $a metastázy nádorové $2 mesh 606 1-
$3 sllk_un_auth*d000077594 $a nivolumab $x použitie terapeutické $x aplikácia a dávkovanie $2 mesh 606 2-
$3 sllk_un_auth*d013534 $a prežívanie $2 mesh 606 2-
$3 sllk_un_auth*d016896 $a výsledok liečby $2 mesh 606 2-
$3 sllk_un_auth*d015331 $a štúdie kohortové $2 mesh 610 2-
$a bezpečnosť liečby 610 2-
$a účinnosť liečby 610 2-
$a vyhodnotenie súboru pacientov 701 -1
$3 sllk_un_auth*p0059470 $a Vrdoljak $b Eduard $p Department of Oncology, Clinical Hospital Split and University of Split school medicine, Split, Croatia $4 070 801 -0
$a SK $b BA006 $c 20210609 $g AACR2
Počet záznamov: 1